Amnioreduction for too much amniotic fluid
Part of Women’s health & pregnancy clinical trials.
This study tests a procedure called amnioreduction to safely remove extra amniotic fluid in pregnant women who have polyhydramnios, which is too much fluid around the baby. The goal is to reduce discomfort and lower the risk of complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and between 20 and 38 weeks along.
- You have been diagnosed with polyhydramnios (too much amniotic fluid).
- You do not have a fatal abnormality in the baby.
- Your water has not broken yet (no pre-labor rupture of membranes).
- You do not have placental abruption (the placenta separating from the uterus).
- You do not have chorioamnionitis (an infection of the amniotic sac).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a specific ultrasound approach can better detect problems with fetal (baby) growth in the later part of pregnancy. It may help identify concerns earlier so your care team can plan the next steps.
This study looks at the fluid around the baby (amniotic fluid) in women with a short cervix or with early breaking of the water (premature rupture of membranes). The goal is to better understand these conditions and possibly improve care.
This study tests a new way to measure amniotic fluid (the liquid around your baby) using ultrasound. It also looks at your baby's bladder to get a clearer picture of how much fluid is available, which may help doctors better monitor pregnancy health.
This study looks at the fluid around your baby (amniotic fluid) and how it might affect your baby's gut health if they are born early. It may help doctors understand how to better care for preterm infants.
This Phase 1 study tests whether repeatedly adding fluid into the amniotic sac (amnioinfusion) can help babies with very severe kidney problems before birth. The goal is to see if this “regenerative therapy” is safe and potentially beneficial, while closely tracking pregnancy and baby outcomes.
This trial tests whether adding fluid into the womb (amnioinfusion) during labor can protect a baby's lungs and health after being exposed to thick meconium (baby's first poop). It may help reduce breathing problems and improve long-term outcomes.
Hear when a new Polyhydramnios trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.